In Vitro Antitumor Activity of the Water Soluble Copper(I) Complexes Bearing the Tris(hydroxymethyl)phosphine Ligand

Citations Over TimeTop 10% of 2008 papers

Abstract

Monocationic hydrophilic complexes [Cu(thp)4](+) 3 and [Cu(bhpe)2](+) 4 were synthesized by ligand exchange reactions starting from the labile [Cu(CH3CN)4][PF6] precursor in the presence of an excess of the relevant hydrophilic phosphine. Complexes 3 and 4 were tested against a panel of several human tumor cell lines. Complex 3 has been shown to be about 1 order of magnitude more cytotoxic than cisplatin. Chemosensitivity tests performed on cisplatin and multidrug resistance phenotypes suggested that complex 3 acts via a different mechanism of action than the reference drug. Different short-term proliferation assays suggested that lysosomal damage is an early cellular event associated with complex 3 cytotoxicity, probably mediated by an increased production of reactive oxygen species. Cytological stains and flow cytometric analyses indicated that the phosphine copper(I) complex is able to inhibit the growth of tumor cells via G2/M cell cycle arrest and paraptosis accompanied with the loss of mitochondrial transmembrane potential.

Related Papers

• → Synthesis of water-soluble (tri(hydroxymethyl)phosphine)gold(I) complexes containing a nucleoside ligand(1994)11 cited
• Effects of human rhabdomyosarcoma cells by combining TRAIL with cisplatin(2006)
• Synergistic effect of TRAIL combined with cisplatin on apoptosis of rhabdomyosarcoma cells(2006)
• Changes and significance of Fas and cFLIP in apoptosis of human rhabdomyosarcoma cells induced by combination of TRAIL and cisplatin(2004)
• Apoptosis of hepatoma cells induced by a combination of TRAIL,Cisplatin and IFN-α(2007)